Lingyu Ding | Oncology | Distinguished Scientist Award

Published on by Health Scientists

Mrs. Lingyu Ding | Oncology | Distinguished Scientist Award

clinical nurse | Jiangsu province hospital | China

Lingyu Ding is a distinguished registered nurse at the Colorectal Surgery Department of The First Affiliated Hospital with Nanjing Medical University, specializing in oncology nursing, perioperative rehabilitation, and cancer-related frailty. She has made significant contributions to the development and validation of frailty assessment models for cancer survivors and has designed and pilot-tested multimodal interventions to manage frailty, demonstrating a strong commitment to improving patient outcomes. Her research has been published extensively in peer-reviewed journals, encompassing systematic reviews, meta-analyses, and observational studies that explore preoperative frailty, sedentary behavior, handgrip strength asymmetry, and postoperative outcomes among older adults with cancer. Lingyu has successfully secured and led a project funded by the National Natural Science Foundation of China, reflecting her leadership and research capabilities, and she actively engages in collaborative projects with multidisciplinary teams. Her work has been recognized with prestigious awards for excellence in professional practice, innovative nursing interventions, and outstanding young talent, underscoring both her academic and clinical impact. Beyond her research, Lingyu contributes to the scholarly community as a peer reviewer for international journals, ensuring the rigor and quality of scientific publications. Her expertise spans both quantitative and qualitative research methodologies, including randomized controlled trials, questionnaire design, phenomenological research, and grounded theory, complemented by proficiency in statistical analysis and academic writing. Through her clinical practice, research, and scholarly activities, Lingyu Ding advances the understanding and management of frailty in cancer patients, bridging the gap between evidence-based research and practical healthcare applications, and making a meaningful impact on patient care, health outcomes, and the broader field of oncology nursing. She has 361 citations from 33 documents with an h-index of 11.

Profile: Scopus 

Featured Publications

1. Willingness, preference, and resistance to frailty intervention for older gastric cancer based on stakeholder perspective: A qualitative study. (2025). BMC Geriatrics. Open access.

2. Clinical characteristics and correlation between preoperative frailty and metabolic syndrome among older patients with gastric cancer. (2025). Chinese General Practice.

3.BMI trajectories, associations with outcomes and predictors in elderly gastric cancer patients undergoing radical gastrectomy: A prospective longitudinal observation study. (2025). Journal of Cancer Survivorship.

Rasha Elsabagh | Oncology | Research Excellence Award

Published on by Health Scientists

Dr. Rasha Elsabagh | Oncology | Research Excellence Award

Researcher | Animal Health Research Institute(AHRI) | Egypt

Rasha H. Elsabagh is a multidisciplinary immunology specialist and cancer stem cell researcher with extensive expertise spanning stem cell biology, immuno-oncology, translational cancer research, and veterinary biomedical sciences. She currently serves as a researcher at the Animal Health Research Institute, where her work integrates advanced immunological diagnostics, molecular biology, and national livestock immunization programs that directly contribute to animal health surveillance and disease control. Her academic training culminated in a doctoral degree in cancer immunology from Cairo University, where her research focused on circulating cancer stem cells and photothermal nanotherapy as predictive and monitoring tools for tumor response. She has conducted advanced international research training at University of California San Francisco, gaining high-level proficiency in flow cytometry, immunofluorescence, and human stem cell analysis, and later expanded her translational oncology experience as a visiting research fellow at the Cancer Institute of Montpellier, working on nanoparticle-mediated RNA delivery to tumor-infiltrating immune cells. Her scientific output includes multiple peer-reviewed publications in high-impact journals and international conference proceedings, with her work receiving sustained scholarly citations and global academic recognition. Her research collaborations span institutions in North America, Europe, and the Middle East, reflecting her active role in international scientific networks in stem cell biology, cancer immunology, and nanomedicine. Beyond laboratory research, she contributes to national capacity building through scientific training, quality assurance in diagnostic immunology, and public health–oriented animal disease control programs. Her work has direct societal impact through improvements in cancer diagnostics, advancement of immunotherapeutic strategies, and strengthening of zoonotic disease surveillance, positioning her as a globally engaged scientist at the intersection of experimental research, translational medicine, and public health. She has 2 citations from 2 documents with an h-index of 1.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Xiao, T., Eze, U. C., Charruyer-Reinwald, A., Weisenberger, T., Khalifa, A., … (2024). Short cell cycle duration is a phenotype of human epidermal stem cells. Stem Cell Research & Therapy, 15(1), 76.

2. Elsabagh, R. H., Farghali, H. A. M., Emam, I. A., Ragab, E., … (2021). Quantitative flow cytometry assessment of feline circulatory breast cancer stem cells. Advances in Animal and Veterinary Sciences, 9(12), 2201–2215.

3. Elsabagh, R. H., Farghali, H. A. M., Emam, I. A., Abdelrahman, H. H., Ragab, E., … (2025). Gold nano-rod (AuNR)-mediated plasmonic photothermal therapy in feline mammary carcinoma: Assessing metastatic and nonmetastatic outcomes. Veterinary Oncology, 2(1), 33.

4. Elsabagh, R. H., Farghali, H. A. M., Emam, I. A., Abdelrahman, H., Ragab, E., … (2022). Prevention of in situ recurrence and distant metastasis in feline mammary carcinoma treated with plasmonic photothermal therapy.

 

Niladry Sekhar Ghosh | Oncology | Best Researcher Award

Published on by Health Scientists

Prof. Niladry Sekhar Ghosh | Oncology | Best Researcher Award

Professor | Assam Down Town University, Guwahati | India

Prof. Niladry Sekhar Ghosh is a distinguished researcher and Professor at Assam Down Town University, Guwahati, serving also as Member Secretary of the Board of Studies, with extensive expertise in pharmaceutical sciences, medicinal chemistry, and biomedical research. He earned his B.Pharm. and M.Pharm. degrees from S.C.S College of Pharmacy, R.G.U.H.S Bangalore, graduating with first-class honors, and completed his Ph.D. at Shobhit University in 2020, focusing on the synthesis of bioactive fluoro-benzothiazole derivatives and the biosynthesis of metallic nanoparticles for biological and pharmacological screening. With over 18 years of teaching experience and significant contributions to research, his key areas of interest include drug discovery, medicinal chemistry, nanotechnology-based drug delivery systems, pharmacological evaluation of bioactive compounds, and cancer therapeutics. Prof. Ghosh has authored more than 50 publications in high-impact journals indexed in SCI, Scopus, and ESCI, including studies on cathepsin inhibitors, benzimidazole and indole derivatives as anticancer agents, and green synthesis of nanoparticles. He has been recognized with multiple honors, notably the Young Teacher Awards by SPER in 2016 and 2018, and has secured competitive research grants from SERB-DST, DBT, ICMR, and NCW for innovative projects in pharmaceutical biotechnology and nanomedicine. Additionally, he holds patents for metallic nanoparticle synthesis and biomedical devices. Beyond research, he serves as a resource person, reviewer, and editor for various scientific journals, contributing to the dissemination of knowledge in medicinal chemistry, pharmacology, and nanotechnology. His leadership roles in academic administration and research guidance underscore his commitment to advancing pharmaceutical education and translational research. He has 90 citations from 22 documents with an h-index of 7.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Dubey, A., Ghosh, N. S., & Singh, R. (2022). Zebrafish as an emerging model: An important testing platform for biomedical science.

2. Dubey, A., Ghosh, N. S., Gupta, A., & Singh, S. (2023). A review on current epidemiology and molecular studies of lumpy skin disease virus—An emerging worldwide threat to domestic animals.

3. Dubey, A., Ghosh, N. S., Agnihotri, N., Kumar, A., Pandey, M., & Nishad, S. (2022). Herbs derived bioactive compounds and their potential for the treatment of neurological disorders.

4. Dubey, A., Ghosh, N. S., Rathor, V. P. S., Patel, S., Patel, B., & Purohit, D. (2022). SARS-CoV-2 infection leads to neurodegenerative or neuropsychiatric diseases.

5. Chandra, D., Yadav, I. K., Jaiswal, D., Ghosh, N., Singh, H. P., Mishra, A., … (Year not specified). Formulation and evaluation of satranidazole microspheres for colon-targeted drug delivery.

Virginie Guastella | Oncology | Best Researcher Award

Published on by Health Scientists

Prof. Dr. Virginie Guastella | Oncology | Best Researcher Award

Associate Professor | University Hospital Clermont-ferrand | France

Dr. Virginie Guastella is a distinguished physician and researcher specializing in palliative care and pain management. She holds a Doctorate in Medicine and an Habilitation à Diriger des Recherches (HDR) focused on opioid analgesics and cancer pain. She currently serves as Head of the Palliative Care Unit at CHU Clermont-Ferrand and as Associate Professor in Palliative Medicine at the University Clermont Auvergne, leading the UIC “Douleur, qualité de vie et maladie grave” within the GRUIC “Douleurs chroniques et thérapeutiques.” Her clinical work emphasizes optimizing pain management, end-of-life care, and therapeutic support for patients with advanced illness, while her research explores critical areas including opioid misuse, the integration of virtual reality and music care in palliative settings, and early detection of chemotherapy-induced neuropathies. She has supervised over 24 medical theses and numerous master-level projects, contributing significantly to clinical education, and is a prolific author with 20 international peer-reviewed publications, multiple national articles, and several book chapters addressing topics from opioid prescribing practices to patient and caregiver experiences in palliative care. Beyond research and clinical responsibilities, she actively participates in national and regional committees, contributes to guideline development, and advocates for palliative medicine education and ethics. Through her combined contributions in research, education, and clinical practice, she has played a pivotal role in advancing patient-centered care, promoting evidence-based practices, and improving the quality of life for patients facing serious illness, establishing herself as a leading figure in palliative care and pain management. She has 485 citations from 41 documents with an h-index of 9.

Profiles: Scopus | ORCID

Featured Publications

1. Lawton, G., Calvel, L., Perceau-Chambard, E., Guastella, V., Economos, G., & Evin, A. (2025). Career trajectories after palliative care training: A national e-survey of medical interns in France.

2. Klaeyle, D., Calvel, L., Perceau-Chambard, E., Guastella, V., Economos, G., & Evin, A. (2025). Teaching palliative medicine in the medical school clerkship in France: A national e-survey.

3. Guastella, V., Lambert, C., Lafforgue, A., Metretin, P., Verstreate, A., Watelet, S., Perceau-Chambard, É., & Lautrette, A. (2024). Withholding or withdrawing life-sustaining treatments in the COVID-19 pandemic.

4. Guastella, V., Delorme, J., Chenaf, C., & Authier, N. (2022). The prevalence of off-label prescribing of transmucosal immediate-release fentanyl in France. Journal of Pain and Symptom Management.

5. Preux, C., Bertin, M., Tarot, A., Authier, N., Pinol, N., Brugnon, D., Pereira, B., & Guastella, V. (2022). Prevalence of opioid use disorder among patients with cancer-related pain: A systematic review.